Skip to content
Holmusk logo — Raising the standards for real-world evidence generation to...

Holmusk

Raising the standards for real-world evidence generation to transform research and care for behavioral health

Founded 2015 United States New York, United States 111 employees Venture round Total: $106.25M AI, Analytics +3

General Information

Company Name Holmusk
Founded Year 2015
Location United States New York, United States
Employees 111
Industries AI, Analytics, Big Data +2
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Holmusk. To contact Holmusk, visit holmusk.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Holmusk compare?

A PDF of Holmusk and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Holmusk soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Holmusk

Holmusk is a data analytics and health technology company that aims to revolutionize research and care for behavioral health. Combining a leading behavioral health database with AI-powered analytics and digital solutions, Holmusk is at the forefront of evidence generation and innovation in the industry. Its core offerings include HolCare EHR+, an electronic health records platform with built-in measurement-based care, and NeuroBlu Research, a robust data analytics solution. Founded in 2015, Holmusk has established itself as a global player with headquarters in Singapore and New York. Notably, the company was recognized as a Technology Pioneer by the World Economic Forum in 2019. In its most recent funding round on 12 October 2023, Holmusk secured a substantial $30.00M investment. This demonstrates the confidence and interest of investors in the company's mission and potential within the AI, Analytics, Big Data, Digital Health, and Health Care industries.

Business keywords: Digital Health, Behavioral Health, Mental Health, Real-world Evidence, Predictive Analytics, Clinical Decision Support, Digital Therapeutics, Pharma, Innovation

Services & Products

Real-World Evidence Platform
Behavioral Health Data Analytics
AI-Powered Healthcare Solutions

Target Customers

Life sciences Providers Payers Government & regulators Academia

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $30.00M -
12 Oct 2023
Corporate Round Undisclosed 1
Veradigm
02 Oct 2023
Series B $45.00M 5
Heritas Capital Management, Novartis +3
09 Jan 2023
Venture Round Undisclosed 5
Heritas Capital Management, Novartis +3
06 Dec 2021
Series A $21.50M 3
Heritas Capital Management, Optum Ventures +1
18 May 2020
Seed Round $9.75M 2
Heritas Capital Management, Capikris Foundation
25 Sep 2018

Holmusk Alternatives & Competitors

View All Alternatives
Holmusk vs
Bayesian Health
Bayesian Health United States

Co-pilot for doctors and nurses — empowering clinicians with real-time care signals to manage outcom...

Venture round
32 employees
AI, Health Care
Holmusk vs
Welldoc
Welldoc United States

Healthcare-Ready AI

Series B
372 employees
AI, Analytics
Holmusk vs
Elfie
Elfie United States

It pays to get better.

Series A
115 employees
Digital Health, Health Care

FAQ About Holmusk

Raising the standards for real-world evidence generation to transform research and care for behavioral health
Holmusk was founded in 2015.
Holmusk is headquartered in New York, United States.
Holmusk operates in AI, Analytics, Big Data, Digital Health and Health Care. Its work centres on Digital Health, Behavioral Health, Mental Health and Real-world Evidence. Its customers include Life sciences, Providers and Payers.
Holmusk has approximately 111 employees.
Holmusk has completed 6 funding rounds, raising a total of $106.25M. The latest funding stage is Venture round.
Holmusk offers: Real-World Evidence Platform, Behavioral Health Data Analytics, AI-Powered Healthcare Solutions.
Top alternatives and competitors to Holmusk include Bayesian Health, Welldoc, Elfie, Cogniant, Behavidence. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Holmusk and Bayesian Health are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Holmusk, https://bouncewatch.com/company/holmusk, updated 26 February 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout